Mercer Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-115,039
Closed -$88.2M 2697
2025
Q2
$88.2M Buy
+115,039
New +$89.4M 0.18% 74

Other funds holding LLY

Mercer Global Advisors's LLY Position: Q2 2026 in Review

Mercer Global Advisors increased its Eli Lilly (LLY) stake by 8.4% in Q2 2026, buying an estimated $15M and bringing the position to 189,731 shares worth $228M. The position accounts for 0.28% of the portfolio, ranked #51.

Mercer Global Advisors first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. The position peaked at $628M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mercer Global Advisors held 189,731 shares of Eli Lilly worth $228M as of Q2 2026.
  • Mercer Global Advisors bought 14,668 Eli Lilly shares in Q2 2026, an estimated $15M.
  • Eli Lilly made up 0.28% of Mercer Global Advisors's portfolio in Q2 2026, its #51 holding.
  • Mercer Global Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • Mercer Global Advisors's Eli Lilly position peaked at $628M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.